Kathleen K. Schoemaker

Iomai CorpVanda Pharmaceuticals Inc.Northstar Neuroscience, Inc.Paratek Pharmaceuticals, Inc.Volcano CorpSomaxon Pharmaceuticals, Inc.Cadence Pharmaceuticals IncSenorx Inc

Cumul. flow

Total declarations

206

Companies

▲ Purchases (64 ops.)

€83.9M

▼ Sales (28 ops.)

€46.3M

Latest filing published 17 Mar 2014 for Achaogen, Inc..

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Closed purchases

Market purchases

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Tobira Therapeutics, Inc. 1 purchase · last 28 Aug 2013
Ocera Therapeutics, Inc. 6 purchases · last 31 Jul 2013
Esperion Therapeutics, Inc. 2 purchases · last 02 Jul 2013
Durata Therapeutics, Inc. 2 purchases · last 24 Jul 2012
Orexigen Therapeutics, Inc. 42 purchases · last 22 Dec 2011
Clovis Oncology, Inc. 2 purchases · last 21 Nov 2011
Zogenix, INC. 4 purchases · last 20 Sept 2011
Alimera Sciences INC 1 purchase · last 27 Apr 2010

Kathleen K. Schoemaker: trading record in brief

This profile gathers the share dealings of Kathleen K. Schoemaker across 23 companies, led by Orexigen Therapeutics, Inc., Volcano Corp and REVA Medical, Inc. Between 6 February 2006 and 19 March 2014, the trades on record add up to 206 filings.

In open-market terms, that means 64 purchases worth €83.9M on one side and 28 sales worth €46.3M on the other. Purchases outweigh sales by €37.6M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 6 share grants.

The median purchase comes to €173k.

The record was last updated on 21 March 2014 with a transaction (€788k) in Cadence Pharmaceuticals Inc. The most recent open-market purchase was published on 28 August 2013, 4,820 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Kathleen K. Schoemaker

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Iomai Corp (US)Vanda Pharmaceuticals Inc. (US)Northstar Neuroscience, Inc. (US)Paratek Pharmaceuticals, Inc. (US)Volcano Corp (US)Somaxon Pharmaceuticals, Inc. (US)

Declarations120 total

●
Kathleen K. Schoemaker
10% OwnerExecutives17 Mar 2014Achaogen, Inc.
0SEC
33,890 sharesCommon StockSEC:0000904454-14-000299:1
●
Kathleen K. Schoemaker
10% OwnerExecutives17 Mar 2014Achaogen, Inc.
0SEC
1,987,049 sharesCommon StockSEC:0000904454-14-000299:0
●
Kathleen K. Schoemaker
10% OwnerExecutives4 Feb 2014Dicerna Pharmaceuticals Inc
0SEC
1,752,707 sharesCommon StockSEC:0000904454-14-000131:0
●
Kathleen K. Schoemaker
10% OwnerExecutives4 Feb 2014Dicerna Pharmaceuticals Inc
0SEC
13,004 sharesCommon StockSEC:0000904454-14-000131:1
●
Kathleen K. Schoemaker
10% OwnerExecutives19 Nov 2013Tandem Diabetes Care Inc
0SEC
3,189,058 sharesCommon StockSEC:0000904454-13-001222:0
●
Kathleen K. Schoemaker
10% OwnerExecutives19 Nov 2013Tandem Diabetes Care Inc
0SEC
54,390 sharesCommon StockSEC:0000904454-13-001222:1
●
Kathleen K. Schoemaker
10% OwnerExecutives4 Nov 2013Veracyte, Inc.
0SEC
3,063,294 sharesCommon StockSEC:0000904454-13-001157:0
●
Kathleen K. Schoemaker
10% OwnerExecutives4 Nov 2013Veracyte, Inc.
0SEC
22,730 sharesCommon StockSEC:0000904454-13-001157:1
●
Kathleen K. Schoemaker
10% OwnerExecutives30 Sept 2013Evoke Pharma Inc
0SEC
1,114,327 sharesCommon StockSEC:0000904454-13-001072:0
●
Kathleen K. Schoemaker
10% OwnerExecutives30 Sept 2013Evoke Pharma Inc
0SEC
19,006 sharesCommon StockSEC:0000904454-13-001072:1
●
Kathleen K. Schoemaker
10% OwnerExecutives27 Aug 2013Tobira Therapeutics, Inc.
0SEC
7,407 sharesCommon StockSEC:0000904454-13-000993:7
●
Kathleen K. Schoemaker
10% OwnerExecutives27 Aug 2013Tobira Therapeutics, Inc.
0SEC
4,233 sharesCommon StockSEC:0000904454-13-000993:5
●
Kathleen K. Schoemaker
10% OwnerExecutives27 Aug 2013Tobira Therapeutics, Inc.
0SEC
2,899 sharesCommon StockSEC:0000904454-13-000993:6
●
Kathleen K. Schoemaker
10% OwnerExecutives27 Aug 2013Tobira Therapeutics, Inc.
0SEC
394,969 sharesCommon StockSEC:0000904454-13-000993:0
●
Kathleen K. Schoemaker
10% OwnerExecutives27 Aug 2013Tobira Therapeutics, Inc.
0SEC
270,568 sharesCommon StockSEC:0000904454-13-000993:1
●
Kathleen K. Schoemaker
10% OwnerExecutives27 Aug 2013Tobira Therapeutics, Inc.
0SEC
894,120 sharesCommon StockSEC:0000904454-13-000993:2
●
Kathleen K. Schoemaker
10% OwnerExecutives27 Aug 2013Tobira Therapeutics, Inc.
0SEC
225,913 sharesCommon StockSEC:0000904454-13-000993:3
●
Kathleen K. Schoemaker
10% OwnerExecutives1 Jul 2013Esperion Therapeutics, Inc.
0SEC
1,786,012 sharesCommon StockSEC:0000904454-13-000762:0
●
Kathleen K. Schoemaker
10% OwnerExecutives1 Jul 2013Esperion Therapeutics, Inc.
0SEC
30,462 sharesCommon StockSEC:0000904454-13-000762:2
●
Kathleen K. Schoemaker
10% OwnerExecutives18 Jan 2013Achillion Pharmaceuticals Inc
0SEC
1,000,000 shares0Common StockSEC:0000904454-13-000048:0
●
Kathleen K. Schoemaker
10% OwnerExecutives18 Jan 2013Achillion Pharmaceuticals Inc
0SEC
66,462 shares0Common StockSEC:0000904454-13-000048:1
●
Kathleen K. Schoemaker
10% OwnerExecutives24 Jul 2012Durata Therapeutics, Inc.
0SEC
16,529 sharesCommon StockSEC:0000904454-12-000364:2
●
Kathleen K. Schoemaker
10% OwnerExecutives24 Jul 2012Durata Therapeutics, Inc.
0SEC
2,227,596 sharesCommon StockSEC:0000904454-12-000364:0
▲
Kathleen K. Schoemaker
10% OwnerExecutives24 Jul 2012Durata Therapeutics, Inc.
7M USD0SEC
778,536 shares@ US$9.00Common StockSEC:0000904454-12-000364:1
Canonical exit: 22 Oct 2012 (T+90)
●
Kathleen K. Schoemaker
10% OwnerExecutives31 May 2012Achillion Pharmaceuticals Inc
0SEC
1,200,000 shares0Common StockSEC:0000904454-12-000300:0

25 of 120 declarations